Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.As of 15 Jun 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,218.10. The stock opened at ₹1,200.00, compared to its previous close of ₹1,181.20. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,193.00 to ₹1,244.20, with an average price of ₹1,218.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,193.00 and a high of ₹1,244.20. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 35.43% over the last six months and is up 62.36% on a year-on-year basis.
The market capitalization of SAI LIFE SCIENCES LIMITED is ₹25,855 Crs, with a P/E ratio of 74.1 and a dividend yield of 0.00%.